This Analyst Believes Precigen’s Non-Healthcare Divesture Removes Financial Overhang
Yesterday, Precigen Inc (NASDAQ: PGEN) agreed to sell its non-healthcare subsidiary to URUS.
Will Constellation Brands Buy Canopy Growth? This Analyst Discusses Optionality Post Debt Transactions
Canopy Growth Corporation (NASDAQ: CGC) entered into a privately negotiated exchange agreement last week with a holder of the company's outstanding 4.25% unsecured senior notes due in 2023, to secure roughly CA$255.4 million ($198 million) aggregate principal amount of the notes from the noteholders in
Rivian Shares Jump 10% After Reaffirming Production Guidance, But Here’s Why Analysts Remain Skeptical
Rivian Automotive Inc (NASDAQ: RIVN) shares traded higher by 13.2% on Wednesday after the company reported impressive production and delivery growth in the second quarter.
6 Analysts Have This to Say About Jackson Finl
Jackson Finl (NYSE:JXN) has observed the following analyst ratings within the last quarter:
6 Analysts Have This to Say About Reinsurance Group
Over the past 3 months, 6 analysts have published their opinion on Reinsurance Group (NYSE:RGA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
What 9 Analyst Ratings Have To Say About Liberty Energy
Within the last quarter, Liberty Energy (NYSE:LBRT) has observed the following analyst ratings:
5 Analysts Have This to Say About BioNTech
BioNTech (NASDAQ:BNTX) has observed the following analyst ratings within the last quarter:
Analyst Ratings for MercadoLibre
Analysts have provided the following ratings for MercadoLibre (NASDAQ:MELI) within the last quarter:
Oppenheimer Maintains Outperform Rating for Focus Finl Partners: Here’s What You Need To Know
Oppenheimer has decided to maintain its Outperform rating of Focus Finl Partners (NASDAQ:FOCS) and lower its price target from $60.00 to $52.00.
Shares of Focus Finl Partners are trading up 1.27% over the last 24 hours, at $35.17 per share.
Piper Sandler Maintains Overweight Rating for SS&C Technologies Hldgs: Here’s What You Need To Know
Piper Sandler has decided to maintain its Overweight rating of SS&C Technologies Hldgs (NASDAQ:SSNC) and lower its price target from $89.00 to $67.00.
Shares of SS&C Technologies Hldgs are trading down 1.08% over the last 24 hours, at $58.60 per share.